Sector: Health Care
Director information for CLOVER HEALTH INVESTMENTS CORP CLA
Board as disclosed in the proxy statement filed April 28, 2026. Titles and roles are as stated in that filing and may have changed since.
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Andrew Toy | Co-Founder, Chief Executive Officer and Director | 47 | [] | [] | 2026 |
| Anna U. Loengard, M.D. | Director | 57 | [] | ["Nominating and Corporate Governance Committee","Clinical Committee"] | 2026 |
| Carladenise Armbrister Edwards Ph.D | Director | 56 | [] | ["Talent and Compensation Committee","Nominating and Corporate Governance Committee","Audit Committee","Clinical Committee"] | 2026 |
| Demetrios L. Kouzoukas | Lead Independent Director | 50 | [] | ["Nominating and Corporate Governance Committee","Audit Committee","Clinical Committee"] | 2026 |
| Peter Kuipers | Chief Financial Officer | [] | [] | 2026 | |
| Thomas L. Tran | Director | 69 | [] | ["Nominating and Corporate Governance Committee","Audit Committee"] | 2026 |
| Vivek Garipalli | Co-Founder and Executive Chairperson | 47 | [] | [] | 2026 |
| William G. Robinson, Jr. | Director | 61 | [] | ["Talent and Compensation Committee","Audit Committee"] | 2026 |
